365 related articles for article (PubMed ID: 17295178)
1. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.
Trauner M; Fickert P; Wagner M
Semin Liver Dis; 2007 Feb; 27(1):77-98. PubMed ID: 17295178
[TBL] [Abstract][Full Text] [Related]
2. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
3. Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect?
Chen HL; Chang PS; Hsu HC; Lee JH; Ni YH; Hsu HY; Jeng YM; Chang MH
Pediatr Res; 2001 Jul; 50(1):50-5. PubMed ID: 11420418
[TBL] [Abstract][Full Text] [Related]
4. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
[TBL] [Abstract][Full Text] [Related]
5. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.
Pauli-Magnus C; Meier PJ; Stieger B
Semin Liver Dis; 2010 May; 30(2):147-59. PubMed ID: 20422497
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy.
Floreani A; Carderi I; Paternoster D; Soardo G; Azzaroli F; Esposito W; Montagnani M; Marchesoni D; Variola A; Rosa Rizzotto E; Braghin C; Mazzella G
Dig Liver Dis; 2008 May; 40(5):366-70. PubMed ID: 18083082
[TBL] [Abstract][Full Text] [Related]
7. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
8. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
[TBL] [Abstract][Full Text] [Related]
9. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.
Keitel V; Vogt C; Häussinger D; Kubitz R
Gastroenterology; 2006 Aug; 131(2):624-9. PubMed ID: 16890614
[TBL] [Abstract][Full Text] [Related]
10. [Liver disease associated with hereditary defects of hepatobiliary transporters].
Wendum D
Ann Pathol; 2010 Dec; 30(6):426-31. PubMed ID: 21167428
[TBL] [Abstract][Full Text] [Related]
11. Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy.
Schneider G; Paus TC; Kullak-Ublick GA; Meier PJ; Wienker TF; Lang T; van de Vondel P; Sauerbruch T; Reichel C
Hepatology; 2007 Jan; 45(1):150-8. PubMed ID: 17187437
[TBL] [Abstract][Full Text] [Related]
12. ABCB4 disease: Many faces of one gene deficiency.
Sticova E; Jirsa M
Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
de Vree JM; Jacquemin E; Sturm E; Cresteil D; Bosma PJ; Aten J; Deleuze JF; Desrochers M; Burdelski M; Bernard O; Oude Elferink RP; Hadchouel M
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):282-7. PubMed ID: 9419367
[TBL] [Abstract][Full Text] [Related]
14. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis.
Lucena JF; Herrero JI; Quiroga J; Sangro B; Garcia-Foncillas J; Zabalegui N; Sola J; Herraiz M; Medina JF; Prieto J
Gastroenterology; 2003 Apr; 124(4):1037-42. PubMed ID: 12671900
[TBL] [Abstract][Full Text] [Related]
15. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
[TBL] [Abstract][Full Text] [Related]
16. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
[TBL] [Abstract][Full Text] [Related]
18. [New molecular aspects of cholestatic liver diseases].
Trauner M; Fickert P; Stauber RE
Z Gastroenterol; 1999 Jul; 37(7):639-47. PubMed ID: 10458013
[TBL] [Abstract][Full Text] [Related]
19. Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications.
Colombo C; Okolicsanyi L; Strazzabosco M
Dig Liver Dis; 2000 Mar; 32(2):152-9. PubMed ID: 10975791
[TBL] [Abstract][Full Text] [Related]
20. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
